[D3-A2] Bioanalysis in Cellular and Gene Therapies: Standardization and Implementation

1:55 PM - 2:25 PM JST(4:55 AM - 5:25 AM UTC)

[D3-A2-02] Key Considerations in Biodistribution Assessment of Cell Therapy Products: Towards Standardization

*Syunsuke Yamamoto¹ (1. Takeda Pharmaceutical Company Limited)

Password required to view

Log in

or